-

BIONIK Laboratories Corp. to Present at Investor Summit Group’s Q3 Virtual Conference

Presentation on Tuesday, August 16th at 2:45pm ET

BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTC Pink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced that Rich Russo, Chief Financial Officer and Interim Chief Executive Officer, will be presenting a corporate overview and meeting with institutional investors at the Q3 Virtual Investor Summit.

Event:

Q3 Investor Summit

Date:

August 16 & 17th, 2022

Presentation:

August 16 @ 2:45 pm ET

Location:

https://us06web.zoom.us/webinar/register/WN_2RDgE-HCTleGLH2yzBv6jQ

About BIONIK Laboratories Corp.

BIONIK Laboratories is a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development.

For more information, please visit www.BIONIKlabs.com and connect with us on Twitter, LinkedIn, and Facebook.

About Investor Summit Group

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt.

Contacts

Conference Contact:
info@investorsummitgroup.com

BIONIK IR Contact:
Stephanie Prince
PCG Advisory
sprince@pcgadvisory.com

BIONIK Laboratories Corp.

OTC Pink:BNKL

Release Versions

Contacts

Conference Contact:
info@investorsummitgroup.com

BIONIK IR Contact:
Stephanie Prince
PCG Advisory
sprince@pcgadvisory.com

More News From BIONIK Laboratories Corp.

Bionik Laboratories Granted United States Patent for Innovative Rehabilitation Technology

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (“Bionik” or the “Company”), a robotics company providing neurological functional recovery solutions to stroke survivors and others with mobility challenges, offering its technology to therapists directly and services to patients in its clinical center, is proud to announce the issuance of United States Patent No. 11,744,763 by the United States Patent and Trademark Office (USPTO). This patent, titled "An Apparatus and/or Method for Positioning...

Bionik Laboratories Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others with mobility challenges, offering its technology to therapists directly and services to patients in its clinical centers, continues to grow its partnership with Lifepoint Health, announcing today its four new installations of the InMotion® ARM robotic device in Phoenix, Arizona, Sacramento, Califor...

Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida

BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility challenges, offering its technology to therapists directly and offering services to patients in its clinical centers, today announced it has experienced a significant increase in patient volume at its rehabilitation center, Tower Physical Therapy & Rehab, in Clermont, FL. During the first eight...
Back to Newsroom